An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population
- 28 February 2008
- journal article
- other
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 22 (5) , 553-562
Abstract
The study examines the effects of the antioxidant flavonoid Pycnogenol on a range of cognitive and biochemical measures in healthy elderly individuals. The study used a double-blind, placebo-controlled, matched-pair design, with 101 elderly participants (60—85 years) consuming a daily dose of 150 mg of Pycnogenol for a three-month treatment period. Participants were assessed at baseline, then at 1, 2, and 3 months of the treatment. The control (placebo) and Pycnogenol groups were matched by age, sex, body mass index, micronutrient intake, and intelligence. The cognitive tasks comprised measures of attention, working memory, episodic memory, and psychomotor performance. The biological measures comprised levels of clinical hepatic enzymes, serum lipid profile, human growth hormone, and lipid peroxidation products. Statistically significant interactions were found for memory-based cognitive variables and lipid peroxidation products, with the Pycnogenol group displaying improved working memory and decreased concentrations of F2-isoprostanes relative to the control group.Keywords
This publication has 45 references indexed in Scilit:
- Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trialThe Lancet, 2007
- Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profileLipids, 2002
- Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseasesNeurobiology of Aging, 2002
- RETRACTED: Effect of vitamin and trace-element supplementation on cognitive function in elderly subjectsNutrition, 2001
- Does oxidative damage to DNA increase with age?Proceedings of the National Academy of Sciences, 2001
- Recent advances in amyotrophic lateral sclerosisCurrent Opinion in Neurology, 2000
- A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteersJournal of Psychopharmacology, 1999
- Systemic Oxidative Stress and Cognitive Performance in the Population-Based EVA StudyFree Radical Biology and Medicine, 1998
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- Association Between Nutritional Status and Cognitive Functioning in a Healthy Elderly PopulationJAMA, 1983